Bosun Asset Management LLC Takes Position in Oscar Health, Inc. $OSCR

Bosun Asset Management LLC purchased a new position in shares of Oscar Health, Inc. (NYSE:OSCR) during the 2nd quarter, HoldingsChannel reports. The institutional investor purchased 48,239 shares of the company’s stock, valued at approximately $1,034,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Thrive Capital Management LLC raised its stake in shares of Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. Wealthspire Advisors LLC bought a new position in Oscar Health in the 1st quarter worth approximately $137,000. Vanguard Group Inc. lifted its holdings in Oscar Health by 3.7% during the 1st quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company’s stock worth $258,247,000 after buying an additional 700,469 shares in the last quarter. Swiss National Bank lifted its holdings in Oscar Health by 1.0% during the 1st quarter. Swiss National Bank now owns 328,200 shares of the company’s stock worth $4,303,000 after buying an additional 3,400 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its position in Oscar Health by 19.0% in the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 501,972 shares of the company’s stock valued at $6,581,000 after buying an additional 79,979 shares during the last quarter. Institutional investors own 75.70% of the company’s stock.

Oscar Health Trading Down 2.4%

NYSE:OSCR opened at $16.77 on Friday. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67. Oscar Health, Inc. has a 1-year low of $11.20 and a 1-year high of $23.80. The firm has a market capitalization of $4.44 billion, a price-to-earnings ratio of -14.97 and a beta of 1.88. The business’s 50-day moving average price is $18.03 and its two-hundred day moving average price is $16.94.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.55) by $0.02. The company had revenue of $2.93 billion during the quarter, compared to analyst estimates of $3.09 billion. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The company’s revenue for the quarter was up 23.2% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.22) EPS. On average, equities analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. UBS Group boosted their target price on Oscar Health from $11.00 to $12.00 and gave the stock a “sell” rating in a research report on Friday, November 7th. The Goldman Sachs Group initiated coverage on Oscar Health in a report on Tuesday, October 14th. They set a “neutral” rating and a $17.00 price objective for the company. Wells Fargo & Company cut their target price on shares of Oscar Health from $14.00 to $11.00 and set an “underweight” rating on the stock in a research report on Thursday, November 13th. Wall Street Zen cut shares of Oscar Health from a “hold” rating to a “sell” rating in a research report on Saturday. Finally, Piper Sandler raised shares of Oscar Health from a “neutral” rating to an “overweight” rating and boosted their price target for the stock from $13.00 to $25.00 in a research note on Tuesday, November 25th. One equities research analyst has rated the stock with a Buy rating, five have given a Hold rating and five have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Reduce” and a consensus price target of $14.86.

Insider Activity

In other Oscar Health news, insider Janet Liang sold 7,338 shares of the company’s stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total value of $121,737.42. Following the completion of the sale, the insider owned 172,527 shares of the company’s stock, valued at approximately $2,862,222.93. This represents a 4.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Richard Scott Blackley sold 25,135 shares of Oscar Health stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $416,989.65. Following the transaction, the chief financial officer directly owned 1,351,034 shares in the company, valued at approximately $22,413,654.06. This represents a 1.83% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 739,472 shares of company stock worth $12,616,880 in the last ninety days. Company insiders own 24.39% of the company’s stock.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.